Mar 2018 $50 M No. 6 $50 to $250 million 1
Twist Bioscience Corp: Raise no. 6, Mar 2018 × Investors in this round 1 investor had bought by the notice of Apr 2, 2018: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Twist Bioscience Corp as a whole in other filings: see Investors below.
What the notice says
Amount sold $50 M of $85 M offered; $35 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bill Marine Peck · Executive Officer Emily Marine Leproust · Executive Officer, Director William Marine Banyai · Executive Officer, Director Bob Marine Ragusa · Director Fred Marine Craves · Director Keith Marine Crandell · Director Minqi Marine Li · Director Paul Marine Conley · Director Rob Marine Chess · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Emily Marine Leproust, President. Source: SEC Form D, newest notice filed Apr 2, 2018. Read the notice at the SEC .
equity SEC Mar 2017 $75 M No. 5 $50 to $250 million 63
Twist Bioscience Corp: Raise no. 5, Mar 2017 × Investors in this round 63 investors had bought by the notice of Dec 29, 2017: 63 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Twist Bioscience Corp as a whole in other filings: see Investors below.
What the notice says
Amount sold $75 M of $75 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bill Marine Peck · Executive Officer Emily Marine Leproust · Executive Officer, Director William Marine Banyai · Executive Officer, Director Bob Marine Ragusa · Director Fred Marine Craves · Director Keith Marine Crandell · Director Paul Marine Conley · Director Rob Marine Chess · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Emily Marine Leproust, President. Source: SEC Form D and 3 amendments, newest notice filed Dec 29, 2017. Read the notice at the SEC .
equity SEC Apr 2016 $3 M Issued in a merger or acquisition $2 to $10 million 46
Twist Bioscience Corp: Private sale, Apr 2016 × Investors in this round 46 investors had bought by the notice of Apr 19, 2016: 46 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Twist Bioscience Corp as a whole in other filings: see Investors below.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bill James Peck · Executive Officer Emily Marine Leproust · Executive Officer, Director Solange James Glaize · Executive Officer William Charles Banyai · Executive Officer, Director Fred James Craves · Director Keith James Crandell · Director Nick James Naclerio · Director Paul James Conley · Director Rob James Chess · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Emily Marine Leproust, President. Source: SEC Form D, newest notice filed Apr 19, 2016. Read the notice at the SEC .
equity SEC Jan 2016 $61 M No. 4 $50 to $250 million 35
Twist Bioscience Corp: Raise no. 4, Jan 2016 × Investors in this round 35 investors had bought by the notice of Jan 20, 2016: 35 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Twist Bioscience Corp as a whole in other filings: see Investors below.
What the notice says
Amount sold $61 M of $61 M offered
Smallest investment taken no minimum stated
What was sold equity, other: Series D Preferred Stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bill James Peck · Executive Officer, Promoter Emily Marine Leproust · Executive Officer, Director, Promoter William Charles Banyai · Executive Officer, Director, Promoter Fred James Craves · Director Keith James Crandell · Director Nick James Naclerio · Director Paul James Conley · Director Rob James Chess · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Emily Marine Leproust, President. Source: SEC Form D, newest notice filed Jan 20, 2016. Read the notice at the SEC .
equity SEC May 2015 $37 M No. 3 $10 to $50 million 28
Twist Bioscience Corp: Raise no. 3, May 2015 × Investors in this round 28 investors had bought by the notice of Jun 11, 2015: 28 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Twist Bioscience Corp as a whole in other filings: see Investors below.
What the notice says
Amount sold $37 M of $37 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bill James Peck · Executive Officer, Promoter Emily Marine Leproust · Executive Officer, Director, Promoter William Charles Banyai · Executive Officer, Director, Promoter Fred James Craves · Director Keith James Crandell · Director Paul James Conley · Director Rob James Chess · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Emily Marine Leproust, President. Source: SEC Form D, newest notice filed Jun 11, 2015. Read the notice at the SEC .
equity SEC May 2014 $26 M No. 2 $10 to $50 million 24
Twist Bioscience Corp: Raise no. 2, May 2014 × Investors in this round 24 investors had bought by the notice of May 28, 2014: 24 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Twist Bioscience Corp as a whole in other filings: see Investors below.
What the notice says
Amount sold $26 M of $27 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Series B Preferred Stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bill James Peck · Executive Officer Emily Marine Leproust · Executive Officer, Director William Charles Banyai · Executive Officer, Director Fred James Craves · Director Keith James Crandell · Director Paul James Conley · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The actual Total Offering Amount was $26,500,000.03 and the actual Total Amount Sold was $25,999,998.55”Signed by Emily Marine Leproust, President. Source: SEC Form D, newest notice filed May 28, 2014. Read the notice at the SEC .
equity SEC Jul 2013 $9 M No. 1 $2 to $10 million 16
Twist Bioscience Corp: Raise no. 1, Jul 2013 × Investors in this round 16 investors had bought by the notice of Feb 10, 2014: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Twist Bioscience Corp as a whole in other filings: see Investors below.
What the notice says
Amount sold $9 M of $9 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Series A Preferred Stock Exemption claimed Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bill James Peck · Executive Officer Emily Marine Leproust · Executive Officer, Director William Charles Banyai · Executive Officer, Director Keith James Crandell · Director Paul James Conley · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The actual Total Offering Amount was $9,298,570.76 and the actual Total Amount Sold was $9,110,713.27”Signed by Emily Leproust, President. Source: SEC Form D and 1 amendment, newest notice filed Feb 10, 2014. Read the notice at the SEC .
equity SEC